The National Institutes of Health (NIH) Consensus Development Project on Criteria for Clinical Trials in Chronic GVHD was supported by:

National Cancer Institute

• Office of the Director
• Cancer Therapy Evaluation Program
• Intramural Research Program and Center for Cancer Research;

National Heart Lung and Blood Institute, Division of Blood Diseases and Resources;

Office of the Director, NIH, Office of Rare Diseases

Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases

Health Resources and Services Administration, Division of Transplantation

Naval Medical Research Center, CW Bill Young/Department of Defense Marrow Donor Recruitment and Research Program

We would also like to acknowledge the following organizations that by their participation made this project possible: American Society for Blood and Marrow Transplantation, European Group for Blood and Marrow Transplantation, Center for International Bone and Marrow Transplant Research, Blood and Marrow Transplant Clinical Trials Network, Canadian Blood and Marrow Transplant Group and Pediatric Blood and Marrow Transplant Consortium. The organizers are also indebted to patients and patient and research advocacy groups who made this process much more meaningful by their engagement. The project group recognizes contributions of numerous colleagues in the field of blood and marrow transplantation nationally and internationally, medical specialists and consultants, pharmaceutical industry, and the National Institutes of Health and US Food and Drug Administration professional staff for their intellectual input, dedication, and enthusiasm.